K HAWKE1, I ISMAIL1, A LEE1, M FAHIM2, A GUPTA1 1Department of Nephrology, Toowoomba Hospital, Queensland; 2Department of Nephrology, Princess Alexandra Hospital, Queensland Aim: We present a lung transplant patient with a diagnosis of sepsis secondary to M morganii PD peritonitis,...
- 9 August 2017
V KHELGI1, 2 A GUPTA1, 2, 1Renal unit, Toowoomba Hospital, Toowoomba, Queensland; 2Rural School of Medicine, University of Queensland Toowoomba, Queensland Background: Chylous ascitis (CA) in peritoneal dialysis (PD) patients is a very rare complication. Due to its milky appearance, it can...
- 9 August 2017
E YII4*, JCG DOERY3,4, Z KAPLAN2,4, PG KERR1,4. 1Department of Nephrology, 2Haematology; 3Pathology – Monash Health; 4Department of Medicine, Monash University, Clayton, Victoria. (* medical student). Aim: To determine the efficay and safety of desferasirox in PD patients. Background: A 54 year...
- 9 August 2017
S CROCKER1 1John Hunter Hospital, Newcastle, New South Wales Background: Peritoneal dialysis (PD) continues to remain a viable dialysis modality with at least 60-90% of home-based patients performing PD across Australia. PD allows patients to maintain greater independence and a more...
- 9 August 2017
K MULRONEY1, T INGLIS2, A CHAKERA1, 3, 1Translational Renal Research Group, Harry Perkins Institute of Medical Research, Perth, Western Australia; 2Department of Microbiology, PathWest Laboratory Medicine, Perth, Australia; 3Renal Unit, Sir Charles Gairdner Hospital, Perth, Western Australia Aim: To use flow cytometry...
- 9 August 2017
D FORTNUM1, N HAWKINS2, G VANDEPEER3, A CHAKERA1,4 1Translational Renal Research Group, Harry Perkins Institute of Medical Research, Perth, Western Australia; 2Hospital in the Home, Sir Charles Gairdner Hospital, Perth, Western Australia; 3Fresenius Medical Care, Perth, Australia; 4Renal Unit, Sir Charles Gairdner Hospital,...
- 9 August 2017
K MULRONEY1, J HALL2, T INGLIS2, A CHAKERA1, 3, 1 Translational Renal Research Group, Harry Perkins Institute of Medical Research, Perth, Western Australia; 2Department of Microbiology, PathWest Laboratory Medicine, Perth, Australia; 3Renal Unit, Sir Charles Gairdner Hospital, Perth, Western Australia Aim: To...
- 9 August 2017
E WILKINS1,2,3, Z STARK1,2,3,, S WHITE1,2,3,4, A MALLETT1,2,5, C QUINLAN1,2,4,6 1KidGen Renal Genetics Flagship, Australian Genomic Health Alliance, Melbourne, VIC; 2Murdoch Childrens Research Institute, Melbourne VIC; 3Victorian Clinical Genetics Service, Melbourne, VIC; 4Department of Paediatrics, University of Melbourne, Melbourne, VIC; 5Kidney Health Service, Royal...
- 9 August 2017
T YOUNG1 , M MANNING1, L PHIPPS1, K FOGO1 1Orange Health Service, NSW Australia Aim: To review a QI project regarding initial access in patient commencing haemodialysis Background: An arteriovenous fistula (AVF) is the preferred initial access in patients new...
- 9 August 2017
AK VIECELLI1, AB IRISH2, CM HAWLEY1, C LOK3, DW JOHNSON1, EM PASCOE1, G STRIPPOLI4, KP POLKINGHORNE5, TA MORI2, S PALMER6 1School of Medicine, University of Queensland, Brisbane, Queensland; 2School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia; 3Department of...
- 9 August 2017